Biopharmaceutical Logistics Market
Biopharmaceutical Logistics Market (Type - Cold Chain Logistics and Non-cold Chain Logistics; Mode of Transportation - Air Shipping, Sea Shipping, Road Shipping, and Rail Shipping; Service - Transportation and Warehousing) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
Press Release :
Biopharmaceutical Logistics Market - Snapshot
The developments in the global biopharmaceutical logistics market is predicted to be shaped by the growing number of approvals for biosimilars across the globe. In addition to that, emerging trend of logistics outsourcing and developments in the network of pharmaceutical distribution is estimated to come as factors favoring expansion of the global biopharmaceutical logistics market over the tenure of assessment.
In accordance with a piece of news published in Generics and Biosimilars Initiative, the European Medicine Agency and the European Commission have approved nearly 18 biosimilars in the year 2017. Following the approvals of so many biosimilars, it is prophesized that the global biopharmaceutical logistics market will make substantial gains in the forthcoming years.
Increased Manufacturing of Products that Need Cold Chain Shipment to Bolster Demand
Rapid technological progress made in the field of logistics is also likely to drive the market over the tenure of assessment. Various technologies such as real time monitoring, mobile cloud solutions, and data mining are expected to play decisive role in driving the demand for biopharmaceutical logistics. Besides, monitoring technology helps the logistic companies through alerts so as to buy information for the execution of contingency plans. As such, utilization of these solutions is estimated to influence growth of the global biopharmaceutical logistics market in the years to come.
A rise in the manufacturing of complex proteins, hormone treatments, vaccine, and biologics that need cold chain shipment is prophesized to bolster the demand for biopharmaceutical logistics in near future. As such, delivery and transportation of various pharmaceutical products that need a certain temperature are likely to make considerable gains in the global biopharmaceutical logistics market.
Based on the parameter of supply chain, the market is bifurcated into
- Cold chain logistics
- Non-cold chain logistic
On the other hand, the cost of operation is quite high as it needs to maintain the quality of temperature sensitive products. This factor is likely to restrict the growth of the market in the years to come.
Global Biopharmaceutical Logistics Market: Snapshot
Logistics is a key component in the biopharmaceutical supply chain. In recent times, a dynamic business environment and a supply chain, which is outlined with greater complexity, have fueled the demand for a more precise and targeted approach to temperature control. Nations around the world are tightening their regulations to ensure secure and reliable transportation of pharmaceutical shipments. This has compelled key players to explore novel technologies to pace up with international standards. For instance, the European Union (EU) is concentrating on strengthening good distribution practices (GDP) guidelines. Given the scenario, companies in the region revamping their technological and regulatory expertise. In line with these developments, investments in biopharmaceutical logistics have considerably increased, thus giving the market significant impetus.
Spurred by the aforementioned factors, the global biopharmaceutical logistics market is forecast to exhibit a CAGR of 6.2% between 2016 and 2024. At this pace, the market will reach to US$120.7 bn by 2024 from US$70.9 bn in 2015.
Air Shipping to Continue Holding Majority Share in Market
In terms of mode of transportation, the market has been segmented into air shipping, sea shipping, road shipping, and rail shipping. Air shipping is set to dominate the biopharmaceutical logistics market, in terms of revenue share, however, sea shipping and road shipping are anticipated to garner maximum volume share of the market during the forecast period. The expansion of the air shipping segment is attributed to air freight being the fastest way of transporting pharmaceutical products with negligible damage or product deterioration, which is especially highly desired for transporting temperature-sensitive vaccines and critical biologic drugs. However, air shipping has a limitation of volume which can be transferred, and hence sea shipping and road shipping will outpace air shipping in volume growth during the forecast period.
Based on type, the global biopharmaceutical logistics market can be bifurcated into cold chain logistics and non-cold chain logistics. With an estimated share of nearly 80%, the non-cold chain logistics segment emerged dominant in the market in 2015. On account of the increasing use of biologics, the demand for cold chain logistics is expected to increase in the coming years. However, the consistent demand for sophisticated delivery and tracking system is expected to seal non-cold chain logistics segment’s dominance through the forecast period.
North America and Europe to Exhibit High Demand for Biopharmaceutical Logistics
Regionally, the market is dominated by North America and Europe. These nations have a high number of exports and imports for biopharmaceuticals, and also are the first ones to introduce advanced technologies for the betterment of transportation and warehousing in the supply chain. In terms of challenges, as the global market for clinical trials expands, there are a few obstacles that manufacturers need to be aware of and clear in order to make shipment arrive in an intact state, at the right temperature, and at the right time. Manufacturers and logistics partners need to be dynamic in responding to changes and navigate through geopolitical hurdles to maintain a superior clinical and commercial supply chain. Moreover, in developing nations, costly biopharmaceuticals going waste due to lack of emphasis on cold chain supply is a challenge which can be overcome to further propel market growth.
For instance, in India, it is reported that close to 25% of vaccines are wasted due to lack of quality supply chain and logistics management system. Improvements planned by the Government in introducing more cold storage facilities in India, is likely to boost market growth in this region.
Key companies profiled in the report include FedEx Corporation, Ceva Logistics LLC, Amerisource Bergen Corporation, Panalpina Group, Kuehne + Nagel International AG, XPO Logistics, Inc., United Parcel Service, Inc., Deutsche Post DHL Group, DB Schenker and C.H. Robinson Worldwide, Inc.
Global Biopharmaceutical Logistics Market: Overview
Logistics is an essential segment of supply chain management. Logistics allows the pharmaceutical companies to establish consistency as well as efficiency through the international supply chain market. The pharmaceutical sector opts logistics for a complete management of acquiring, storing and moving the resources to the end users as per their needs. Logistics provides a continuous supply of bio pharmaceutical products like vaccines, anti-bodies, somatic cells and other biomolecules from sellers and traders in different places. It also allows the transport of pharmaceutical drugs which do not require cold chain control. Nowadays, the pharmaceutical companies have even started to outsource the logistics domain of the company to the third parties. Logistics market is gaining popularity due to fast track execution and better communication, even this market is in constant process to reduce packaging costs. The market has also witnessed rapid growth due to mergers and acquisitions by the existing players. The market for biopharmaceutical logistics shall be driven by factors such as logistics providers having local contacts and know-how, innovation in packaging and increased manufacture and use of biologic drugs.
Global Biopharmaceutical Logistics Market: Scope of the Report
This report on the global biopharmaceutical logistics market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Detailed qualitative analysis of factors responsible for driving and restraining market growth and opportunities has been provided in the market overview section. Market revenue in terms of US$ Bn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market volume data (tonnage) for the period 2014 to 2024 has been provided for the mode of transportation segment at regional and country level.
Market related factors such as technological developments, service innovations, expansion of infrastructural facilities such as warehousing networks by major players and historical year-on-year growth have been taken into consideration while estimating the market size. Growth rates for each segment within the global biopharmaceutical logistics market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the global market.
Global Biopharmaceutical Logistics Market: Segmentation
Based on type, the global biopharmaceutical logistics market has been segmented into cold chain logistics and non-cold chain logistics. Although the overall pharmaceutical market has more products requiring non-cold chain based logistics transport, the market for cold chain is witnessing a higher growth rate owing to the rise in manufacture and transport of biologic drugs and those drugs which require temperature controlled shipping.
The principal modes of transportation for biopharmaceutical logistics include air shipping, sea shipping, road shipping and rail shipping. New regulations in the U.S., the European Union, and elsewhere, has radically lengthened the list of drugs requiring temperature-controlled handling. Specifically, new rules for handling products that fall into the controlled ambient (15 to 25 degrees C) category has upsurged the demand for temperature controlled handling. This has led to many pharmaceutical companies resorting to air shipping for such critical products. However, concerns over cost containment has led to the trend of increased preference for transporting pharmaceuticals by sea and road, wherever possible.
Geographically, the global Biopharmaceutical Logistics market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been further segmented by major countries. Considerable growth in biopharma logistics is expected in the emerging countries in Asia compared to North America and Europe.
Companies Mentioned in the Report
The report also profiles major players in the Biopharmaceutical Logistics market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include FedEx Corporation, Ceva Logistics LLC, Amerisource Bergen Corporation, Panalpina Group, Kuehne + Nagel International AG, XPO Logistics, Inc., United Parcel Service, Inc., Deutsche Post DHL Group, DB Schenker and C.H. Robinson Worldwide, Inc.
The global biopharmaceutical logistics market has been segmented as follows:
by Mode of Transportation